-
Resazurin Cell Viability Assay Kit for Wnt Studies
2026-08-27
Use a sensitive, non-toxic redox readout to separate Wnt-driven changes in osteoblast activity from treatment-related cell loss. The Resazurin Cell Viability Assay Kit adds a rapid fluorescence or colorimetric checkpoint to LGK974 experiments, dose-response studies, and high-throughput screening workflows.
-
GTP Solution: From Stock Integrity to RNA Evidence
2026-08-27
GTP Solution (100 mM) supports controlled nucleotide handling from in vitro transcription through localized p21 mRNA research. This article presents an assay-centered framework for connecting GTP quality, RNA characterization, lipid nanoparticle delivery, and biologically interpretable bladder cancer endpoints.
-
Meropenem Trihydrate and the Next AMR Decision Layer
2026-08-26
Meropenem trihydrate is more than a broad-spectrum carbapenem antibiotic: it can serve as a mechanistic probe for linking cell-wall stress, resistance phenotypes, and metabolomic signatures. This thought-leadership article outlines how translational researchers can integrate the compound into resistance profiling, infection-model validation, and carefully bounded preclinical studies.
-
Cefodizime: From PBP Biology to Resistance Strategy
2026-08-26
A translational perspective on Cefodizime that connects PBP-targeted bactericidal activity, susceptibility testing, immunomodulatory biology, pharmacokinetic context, and antimicrobial stewardship.
-
FerroOrange for Live-Cell Fe²⁺ Detection
2026-08-25
FerroOrange is a live-cell Fe²⁺ fluorescent probe for connecting labile ferrous iron signals with neuronal injury, microglial activation, and ferroptosis workflows. This practical guide covers imaging, flow cytometry, plate-based assays, protocol design, and troubleshooting around the Cdk5–AMPK stroke study.
-
Asunaprevir (BMS-650032) HCV Assay Guide
2026-08-25
Asunaprevir (BMS-650032) combines nanomolar NS3/4A protease inhibition with activity across diverse HCV subtypes, making it useful for biochemical, replicon, and cell-based antiviral workflows. This guide explains how to handle the water-insoluble compound, connect protease inhibition to HCV RNA replication inhibition, and troubleshoot assay results without overinterpreting cross-domain oncology evidence.
-
5-Methyl-CTP: An Assay-to-Vaccine Design Guide
2026-08-24
Discover how 5-Methyl-CTP can be evaluated as a controllable variable in mRNA synthesis with modified nucleotides. This guide connects transcript-level quality assays with translational lessons from an H5N1 mRNA vaccine study in dairy cattle.
-
GTP Solution for p21 mRNA-LNP Workflows
2026-08-24
A ready-to-use GTP Solution supports controlled RNA synthesis, from p21 mRNA production to downstream lipid nanoparticle testing. This article translates the bladder cancer study into practical nucleotide handling, assay design, and troubleshooting decisions while distinguishing evidence-backed findings from workflow starting points.
-
GTP Solution for Reproducible mRNA Workflows
2026-08-23
See how a defined GTP input supports in vitro transcription, RNA quality control, and downstream mRNA–LNP studies. This practical guide connects nucleotide handling with the localized p21 mRNA delivery strategy reported for bladder cancer while keeping reagent effects separate from delivery biology.
-
Bacitracin (B1670): Practical Lab Protocol
2026-08-22
Bacitracin (B1670) provides a research-grade peptide antibiotic for controlled studies of bacterial cell wall and peptidoglycan synthesis disruption. It is intended for laboratory antibacterial research only and should not be used for diagnostic, clinical, or medical applications.
-
DAT PET Tracks Dopaminergic Neuron Maturation
2026-08-21
Goggi et al. showed that longitudinal dopamine transporter PET can assess the survival, maturation, and presynaptic integration of transplanted human embryonic stem cell-derived midbrain dopaminergic neurons in a rat model of Parkinson’s disease. The study also demonstrates why imaging should be interpreted alongside behavioral and histological endpoints when evaluating cell-replacement therapies.
-
Hematoxylin and Eosin Staining Kit: Protocol
2026-08-21
The Hematoxylin and Eosin Staining Kit provides ready-to-use hematoxylin and eosin solutions for consistent visualization of nuclei, cytoplasm, and extracellular matrix in tissue sections and cytological preparations. It is intended for scientific research involving paraffin-embedded, frozen, or cytological samples, not for diagnostic or medical use.
-
Intravesical p21 mRNA-LNP for Bladder Cancer
2026-08-20
The reference study develops chemically modified CDKN1A/p21 mRNA encapsulated in lipid nanoparticles for localized intravesical treatment of bladder cancer. Its preclinical evidence connects nuclear p21 restoration with cell-cycle inhibition, DNA damage, apoptosis, bladder-localized expression, and reduced tumor growth, while also defining important limits for translation.
-
Nigericin Sodium Salt as a Mechanistic Assay Probe
2026-08-20
Nigericin sodium salt is a potassium ionophore that links K+/H+ exchange to experimentally interpretable changes in cytoplasmic pH, ion gradients, and cell-state readouts. This guide integrates its mechanistic uses with a measurement framework for separating growth inhibition from cell death in vitro.
-
Fasting, eIF4E Translation, and Tumorigenesis
2026-08-19
Yang and colleagues show that fasting reduces global liver translation while selectively increasing translation of mRNAs required for lipid catabolism and ketogenesis through phosphorylated eIF4E. Their work identifies a fatty-acid–AMPK–MNK–eIF4E axis and demonstrates that inhibiting this pathway can restrain pancreatic tumor growth during a ketogenic diet, linking nutritional state to translational control and cancer biology.